About US
Contact us
-
Branded drug prices leap 13% in U.S., far outpacing inflationWhile the pharma industry worries about drug spending cuts around the world, companies can still take heart from the good old U.S. of A. Drugmakers raised branded prices by 13.3%, more than 6 times t2012/11/29
-
Beactica Extends Fragment-Based Discovery Research Services AgreementBeactica, the leading Swedish fragment-based drug discovery company, today announced that it has added a project under its ongoing research services agreement with Janssen Research & Development2012/11/29
-
Bayer, Regeneron get EU nod for Eylea, next stop JapanBayer and partner Regeneron ($REGN) have notched another win for Eylea, getting approval for the eye drug in Europe for treating wet age-related macular degeneration. Eylea is already approved in t2012/11/28
-
Schott to expand pharmaceutical packaging manufacturing in RussiaSchott Pharmaceutical Packaging has revealed plans to increase production capacity at its Russian plant in Zavolzhe. The German company intends to boost capacity by more than 50 per cent in a move th2012/11/28
-
Global diabetes drugs market set for 9.7pc annual growthThe global market for diabetes drugs will grow at a compound annual growth rate (CAGR) of 9.7 per cent between 2011 and 2015, analysts have predicted.TechNavio's latest report highlights the rising nu2012/11/27
-
Investors accuse Pfizer of trashing data on Celebrex, BextraDisgruntled Pfizer ($PFE) investors are accusing the company of a cover-up. In documents filed in a securities-fraud lawsuit, the investor group says Pfizer trashed some records and denied the existe2012/11/27
-
No bills from pharma, health sectors likely to come up for discussion during Winter SessionNo bills from the pharma and health sectors, including the controversial National Biotechnology Regulatory Authority (NBRA) bill, may be introduced during the Winter Session commencing on November 222012/11/26
-
Ranbaxy trips over generic LipitorRanbaxy Laboratories has stumbled again, only about 7 months after its return from FDA banishment from the U.S. market. And it has tripped up on the drug that powered it to a massive first quarter in2012/11/26
-
Hyderabad to host intl conference on pharma, bioanalytics and cosmetics from November 22 to 24A series of international conferences and exhibitions on pharma regulatory affairs, analytical & bioanalytical techniques, cosmetics & cosmetology and food processing technology are set to be2012/11/23
-
New pharma policy to be ready by Nov 27 as GoM hammers out ‘consensus’ over possible pricing formulaPushed by the Supreme Court to finalise the National Pharmaceutical Pricing Policy before November 27, the Group of Ministers (GoM) on Wednesday claimed to have settled the differences among the key2012/11/23